Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
The use of zebrafish larvae in basic and applied research has grown exponentially during the last 20 years. The reasons for this success lay in its specific experimental advantages: on the one hand, the small size, the large number of progeny and the fast life cycle greatly facilitate large-scale ap...
Main Authors: | Carles Cornet, Vincenzo Di Donato, Javier Terriente |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00703/full |
Similar Items
-
Cell and small animal models for phenotypic drug discovery
by: Szabo M, et al.
Published: (2017-06-01) -
ZeOncoTest: Refining and Automating the Zebrafish Xenograft Model for Drug Discovery in Cancer
by: Carles Cornet, et al.
Published: (2019-12-01) -
Knockout and phenotype analysis of lkb1 gene in zebrafish by CRISPR/Cas9 technology
by: LIANG Sen, et al.
Published: (2019-08-01) -
Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
by: Yan Feng, et al.
Published: (2016-08-01) -
Functional Analysis of Zebrafish Paralogs, parla and parlb, by CRISPR-Cas9 Mediated Mutagenesis
by: Jung, Megan
Published: (2017)